H40.63 Glaucoma secondary to drugs, bilateral

Name of the Condition

• Glaucoma Secondary to Drugs, Bilateral

Summary

Glaucoma secondary to drugs, bilateral, is a condition characterized by increased intraocular pressure (IOP) or optic nerve damage in both eyes resulting from the use of certain medications. This form of glaucoma may develop due to the pharmacological effects of drugs on the eye’s drainage structures or optic nerve, potentially leading to vision loss if not identified and managed promptly.

Causes

The condition arises when medications disrupt the eye’s normal fluid drainage or damage the optic nerve. Common mechanisms include drugs that alter the trabecular meshwork, reduce aqueous humor outflow, or directly affect optic nerve health. Examples include corticosteroids, certain antidepressants, and some anticholinergic agents, which can elevate IOP or cause optic nerve changes over time.

Risk Factors

• Prolonged use of corticosteroid medications (topical, inhaled, or systemic).
• Use of drugs known to affect intraocular pressure (e.g., some anticholinergics, antipsychotics).
• Pre-existing ocular conditions that increase susceptibility to drug-induced pressure changes.
• Genetic predisposition to steroid responsiveness.

Symptoms

• Elevated intraocular pressure (detected via tonometry) in both eyes.
• Vision changes, such as blurred vision or halos around lights in both eyes.
• Eye discomfort or pain (less common).
• Progressive vision loss, particularly in peripheral vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including tonometry to measure IOP, visual field testing to assess optic nerve damage, and a review of medication history. Imaging or additional tests may be used to rule out other causes of elevated IOP or optic nerve changes.

Treatment Options

Treatment focuses on discontinuing or adjusting the causative medication, if possible, and managing IOP with topical or systemic medications. In some cases, laser therapy or surgery may be necessary to reduce pressure and prevent further damage.

Prognosis and Follow-Up

Prognosis depends on early detection and management. Regular follow-up appointments are essential to monitor IOP, optic nerve health, and vision. Prompt intervention can help preserve vision, but delayed treatment may lead to permanent vision loss.

Complications

Untreated or poorly managed cases can result in permanent vision loss, optic nerve damage, or blindness. Bilateral involvement increases the risk of significant visual impairment.

Lifestyle & Prevention

• Avoid or limit use of medications known to elevate IOP, when possible.
• Regular eye examinations, especially for individuals on long-term drug therapy.
• Inform healthcare providers of any ocular symptoms or changes in vision.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden vision changes, eye pain, or halos around lights, as these may indicate acute pressure elevation requiring urgent care.

Tips for Medical Coders

Document the bilateral nature of the condition and the specific medications involved, as these details support accurate coding. Ensure the medical record reflects the relationship between drug use and glaucoma development to justify the diagnosis.